Europe Human Insulin Market Size, Share & Trends Analysis Report By Indication, By Product Type (Pens, Syringes, and Others), By Type of Insulin, By Distribution Channel, By Country and Growth Forecast, 2024

List of Tables

The Europe Human Insulin Market would witness market growth of 2.9% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Human Insulin Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,389.5 million by 2031. The UK market is exhibiting a CAGR of 2% during (2024 - 2031). Additionally, The France market would experience a CAGR of 4% during (2024 - 2031).

Advancements in insulin delivery systems have also contributed significantly to the growth of the insulin market. Insulin pens, for example, offer a more user-friendly and portable alternative to traditional vial-and-syringe methods, making insulin administration less intimidating and more accurate. Government initiatives and healthcare policies are crucial in shaping the human insulin market. Public health campaigns and educational initiatives also raise awareness about diabetes prevention and management, encouraging early diagnosis and proper treatment.

Rising awareness and education about diabetes management and the importance of insulin therapy have significantly improved diagnosis rates and treatment adherence. Public health campaigns, patient and provider education programs, initiatives in schools and workplaces, the efforts of non-profit organizations, and technological advancements have all contributed to this positive trend. These endeavors have improved health outcomes, enhanced the quality of care, and promoted the growth of the insulin market by ensuring that individuals are well-informed about diabetes and the critical role of insulin in its management.

France is experiencing a similar trend, with an aging population contributing to the increasing demand for insulin. According to the French National Institute of Statistics and Economic Studies (INSEE), in 2040, there would be 51 people aged 65 or over per 100 people aged 20 to 64, compared with 37 in 2021. The French Health Ministry estimates that approximately 3.5 million people in France have diabetes, and the prevalence is higher among older adults. Public health campaigns and initiatives by the French government aim to improve diabetes detection and management, ensuring patients receive appropriate care. The growing number of senior people in France, which has led to an increase in the number of people diagnosed with diabetes, is the primary factor driving the need for the insulin in the country. Hence, these elements will support the regional market's growth in the coming years.

Based on Indication, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes. Based on Product Type, the market is segmented into Pens, Syringes, and Others. Based on Type of Insulin, the market is segmented into Rapid-acting insulin, Short-acting insulin, Intermediate-acting insulin, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

MannKind Corporation
Lupin Limited
Sanofi S.A.
Novo Nordisk A/S
Eli Lilly And Company
Medtronic PLC
Biocon Limited
Tonghua Dongbao Pharmaceutical Co., Ltd.
Pfizer, Inc.

Europe Human Insulin Market Report Segmentation

By Indication

Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes

By Product Type

Pens
Syringes
Others

By Type of Insulin

Rapid-acting insulin
Short-acting insulin
Intermediate-acting insulin
Others

By Distribution Channel

Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Providers

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Human Insulin Market, by Indication
- 1.4.2 Europe Human Insulin Market, by Product Type
- 1.4.3 Europe Human Insulin Market, by Type of Insulin
- 1.4.4 Europe Human Insulin Market, by Distribution Channel
- 1.4.5 Europe Human Insulin Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Europe Human Insulin Market by Indication

4.1 Europe Type 1 Diabetes Market by Country
4.2 Europe Type 2 Diabetes Market by Country
4.3 Europe Gestational Diabetes Market by Country

Chapter 5. Europe Human Insulin Market by Product Type

5.1 Europe Pens Market by Country
5.2 Europe Syringes Market by Country
5.3 Europe Others Market by Country

Chapter 6. Europe Human Insulin Market by Type of Insulin

6.1 Europe Rapid-acting insulin Market by Country
6.2 Europe Short-acting insulin Market by Country
6.3 Europe Intermediate-acting insulin Market by Country
6.4 Europe Others Market by Country

Chapter 7. Europe Human Insulin Market by Distribution Channel

7.1 Europe Hospital Pharmacies Market by Country
7.2 Europe Drug Stores & Retail Pharmacies Market by Country
7.3 Europe Online Providers Market by Country

Chapter 8. Europe Human Insulin Market by Country

8.1 Germany Human Insulin Market
- 8.1.1 Germany Human Insulin Market by Indication
- 8.1.2 Germany Human Insulin Market by Product Type
- 8.1.3 Germany Human Insulin Market by Type of Insulin
- 8.1.4 Germany Human Insulin Market by Distribution Channel
8.2 UK Human Insulin Market
- 8.2.1 UK Human Insulin Market by Indication
- 8.2.2 UK Human Insulin Market by Product Type
- 8.2.3 UK Human Insulin Market by Type of Insulin
- 8.2.4 UK Human Insulin Market by Distribution Channel
8.3 France Human Insulin Market
- 8.3.1 France Human Insulin Market by Indication
- 8.3.2 France Human Insulin Market by Product Type
- 8.3.3 France Human Insulin Market by Type of Insulin
- 8.3.4 France Human Insulin Market by Distribution Channel
8.4 Russia Human Insulin Market
- 8.4.1 Russia Human Insulin Market by Indication
- 8.4.2 Russia Human Insulin Market by Product Type
- 8.4.3 Russia Human Insulin Market by Type of Insulin
- 8.4.4 Russia Human Insulin Market by Distribution Channel
8.5 Spain Human Insulin Market
- 8.5.1 Spain Human Insulin Market by Indication
- 8.5.2 Spain Human Insulin Market by Product Type
- 8.5.3 Spain Human Insulin Market by Type of Insulin
- 8.5.4 Spain Human Insulin Market by Distribution Channel
8.6 Italy Human Insulin Market
- 8.6.1 Italy Human Insulin Market by Indication
- 8.6.2 Italy Human Insulin Market by Product Type
- 8.6.3 Italy Human Insulin Market by Type of Insulin
- 8.6.4 Italy Human Insulin Market by Distribution Channel
8.7 Rest of Europe Human Insulin Market
- 8.7.1 Rest of Europe Human Insulin Market by Indication
- 8.7.2 Rest of Europe Human Insulin Market by Product Type
- 8.7.3 Rest of Europe Human Insulin Market by Type of Insulin
- 8.7.4 Rest of Europe Human Insulin Market by Distribution Channel

Chapter 9. Company Profiles

9.1 Biocon Limited
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Research & Development Expenses
9.2 Tonghua Dongbao Pharmaceutical Co., Ltd.
- 9.2.1 Company Overview
9.3 Lupin Limited
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 SWOT Analysis
9.4 MannKind Corporation
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
9.5 Sanofi S.A.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 SWOT Analysis
9.6 Novo Nordisk A/S
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental & Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 SWOT Analysis
9.7 Medtronic PLC
- 9.7.1 Company overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
9.8 Eli Lilly And Company
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 SWOT Analysis
9.9 Pfizer, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional & Segmental Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis

LIST OF TABLES

TABLE 1 Europe Human Insulin Market, 2020 - 2023, USD Million
TABLE 2 Europe Human Insulin Market, 2024 - 2031, USD Million
TABLE 3 Europe Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 4 Europe Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 5 Europe Type 1 Diabetes Market by Country, 2020 - 2023, USD Million
TABLE 6 Europe Type 1 Diabetes Market by Country, 2024 - 2031, USD Million
TABLE 7 Europe Type 2 Diabetes Market by Country, 2020 - 2023, USD Million
TABLE 8 Europe Type 2 Diabetes Market by Country, 2024 - 2031, USD Million
TABLE 9 Europe Gestational Diabetes Market by Country, 2020 - 2023, USD Million
TABLE 10 Europe Gestational Diabetes Market by Country, 2024 - 2031, USD Million
TABLE 11 Europe Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 12 Europe Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 13 Europe Pens Market by Country, 2020 - 2023, USD Million
TABLE 14 Europe Pens Market by Country, 2024 - 2031, USD Million
TABLE 15 Europe Syringes Market by Country, 2020 - 2023, USD Million
TABLE 16 Europe Syringes Market by Country, 2024 - 2031, USD Million
TABLE 17 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 18 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 19 Europe Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 20 Europe Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 21 Europe Rapid-acting insulin Market by Country, 2020 - 2023, USD Million
TABLE 22 Europe Rapid-acting insulin Market by Country, 2024 - 2031, USD Million
TABLE 23 Europe Short-acting insulin Market by Country, 2020 - 2023, USD Million
TABLE 24 Europe Short-acting insulin Market by Country, 2024 - 2031, USD Million
TABLE 25 Europe Intermediate-acting insulin Market by Country, 2020 - 2023, USD Million
TABLE 26 Europe Intermediate-acting insulin Market by Country, 2024 - 2031, USD Million
TABLE 27 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 28 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 29 Europe Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 30 Europe Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 31 Europe Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 32 Europe Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 33 Europe Drug Stores & Retail Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 34 Europe Drug Stores & Retail Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 35 Europe Online Providers Market by Country, 2020 - 2023, USD Million
TABLE 36 Europe Online Providers Market by Country, 2024 - 2031, USD Million
TABLE 37 Europe Human Insulin Market by Country, 2020 - 2023, USD Million
TABLE 38 Europe Human Insulin Market by Country, 2024 - 2031, USD Million
TABLE 39 Germany Human Insulin Market, 2020 - 2023, USD Million
TABLE 40 Germany Human Insulin Market, 2024 - 2031, USD Million
TABLE 41 Germany Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 42 Germany Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 43 Germany Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 44 Germany Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 45 Germany Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 46 Germany Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 47 Germany Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 48 Germany Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 49 UK Human Insulin Market, 2020 - 2023, USD Million
TABLE 50 UK Human Insulin Market, 2024 - 2031, USD Million
TABLE 51 UK Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 52 UK Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 53 UK Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 54 UK Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 55 UK Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 56 UK Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 57 UK Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 58 UK Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 59 France Human Insulin Market, 2020 - 2023, USD Million
TABLE 60 France Human Insulin Market, 2024 - 2031, USD Million
TABLE 61 France Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 62 France Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 63 France Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 64 France Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 65 France Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 66 France Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 67 France Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 68 France Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 69 Russia Human Insulin Market, 2020 - 2023, USD Million
TABLE 70 Russia Human Insulin Market, 2024 - 2031, USD Million
TABLE 71 Russia Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 72 Russia Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 73 Russia Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 74 Russia Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 75 Russia Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 76 Russia Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 77 Russia Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 78 Russia Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 79 Spain Human Insulin Market, 2020 - 2023, USD Million
TABLE 80 Spain Human Insulin Market, 2024 - 2031, USD Million
TABLE 81 Spain Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 82 Spain Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 83 Spain Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 84 Spain Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 85 Spain Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 86 Spain Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 87 Spain Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 88 Spain Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 89 Italy Human Insulin Market, 2020 - 2023, USD Million
TABLE 90 Italy Human Insulin Market, 2024 - 2031, USD Million
TABLE 91 Italy Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 92 Italy Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 93 Italy Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 94 Italy Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 95 Italy Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 96 Italy Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 97 Italy Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 98 Italy Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 99 Rest of Europe Human Insulin Market, 2020 - 2023, USD Million
TABLE 100 Rest of Europe Human Insulin Market, 2024 - 2031, USD Million
TABLE 101 Rest of Europe Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 102 Rest of Europe Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 103 Rest of Europe Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 104 Rest of Europe Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 105 Rest of Europe Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 106 Rest of Europe Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 107 Rest of Europe Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 108 Rest of Europe Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 109 Key Information - Biocon Limited
TABLE 110 Key Information - Tonghua Dongbao Pharmaceutical Co., Ltd.
TABLE 111 Key Information - Lupin Limited
TABLE 112 Key Information - MannKind Corporation
TABLE 113 Key Information - Sanofi S.A.
TABLE 114 Key Information - Novo Nordisk A/S
TABLE 115 Key Information - Medtronic PLC
TABLE 116 Key Information - Eli Lilly And Company
TABLE 117 Key Information - Pfizer, Inc.

Europe Human Insulin Market Size, Share & Trends Analysis Report By Indication, By Product Type (Pens, Syringes, and Others), By Type of Insulin, By Distribution Channel, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents